Differences in outcomes between oral anticoagulation “new starters” and “switchers” in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials

BACKGROUND: To explore differences in outcomes between dose‐adjusted vitamin K antagonists (VKAs) “new starters” and “switchers” in patients with nonvalvular atrial fibrillation (AF). METHODS: A post hoc analysis was performed to assess the outcome differences between VKA “new starters” and “switche...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Ying, Shantsila, Alena, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898535/
https://www.ncbi.nlm.nih.gov/pubmed/31844472
http://dx.doi.org/10.1002/joa3.12255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898535/
https://www.ncbi.nlm.nih.gov/pubmed/31844472
http://dx.doi.org/10.1002/joa3.12255

Ejemplares similares